A. Bye

Publication List Details

Period

1975 - 2008

Number

30

Co-Authors

Gene expression profiling of skeletal muscle in exercise-trained and sedentary rats with inborn high and low VO2max (2008)

Bye, A., Hoydal, M.A., Catalucci, D., Langaas, M., Kemi, O.J., Beisvag, V., ...

The relationship between inborn maximal oxygen uptake (VO2max) and skeletal muscle gene expression is unknown. Since low VO2max is a strong predictor of cardiovascular mortality, genes related to low...

Aerobic capacity-dependent differences in cardiac gene expression (2008)

Bye, A., Langaas, M., Høydal, M.A., Kemi, O.J., Heinrich, G., Koch, L.G., ...

Aerobic capacity is a strong predictor of cardiovascular mortality. To determine the relationship between inborn aerobic capacity and cardiac gene expression we examined genome-wide gene expression...

Aerobic capacity-dependent differences in cardiac gene expression (2007)

Bye, A., Langaas, M., Hoydal, M.A., Kemi, O.J., Heinrich, G., Koch, L.G., ...

Aerobic capacity is a strong predictor of cardiovascular mortality. To determine the relationship between inborn aerobic capacity and cardiac gene expression we examined genome-wide gene expression...

Rational Dose Selection for a Nonnucleoside Reverse Transcriptase Inhibitor through Use of Population Pharmacokinetic Modeling and (2001)

Monte Carlo Simulation, G. L. Drusano, J. P. Kleim, W. Prince, A. Bye

In order to choose a rational dose for GW 420867X, we first set a goal of therapy. We hypothesized that, for optimal antiretroviral activity, the trough free drug concentration should remain above...

Human pharmacokinetics of acyclovir (an antiviral agent) following rapid intravenous injection (1981)

Brigden, D., Bye, A., Fowle, A.S.E., Rogers, H.

Acyclovir [9-(2 hydroxyethoxymethyl)guanine] an acyclic nucleoside of guanine with potent antiviral activity against the herpes simplex virus both in vitro and topically in man was injected as a...

Concentrations of trimethoprim and sulphamethoxazole in aqueous humour and plasma from regimens of co-trimoxazole in man (1975)

Salmon, J. D., Fowle, A. S. W., Bye, A.

Aqueous humour was sampled simultaneously with plasma from patients under going cataract surgery. All the patients had taken co-trimoxazole for various periods ending at various intervals before...

Use of Drug Effect Interaction Modeling with Monte Carlo Simulation To Examine the Impact of Dosing Interval on the Projected Antiviral Activity of the Combination of Abacavir and Amprenavir

Drusano, G. L., D'Argenio, D. Z., Preston, S. L., Barone, C., Symonds, W., LaFon, S., ...

The delineation of optimal regimens for combinations of agents is a difficult problem, in part because, to address it, one needs to (i) have effect relationships between the pathogen in question and...

Nucleoside Analog 1592U89 and Human Immunodeficiency Virus Protease Inhibitor 141W94 Are Synergistic In Vitro

Drusano, G. L., D’Argenio, D. Z., Symonds, W., Bilello, P. A., McDowell, J., Sadler, B., ...

The use of combinations of anti-human immunodeficiency virus (anti-HIV) agents targeted to different molecular targets will most likely result in increased viral suppression and may also delay or...

Pharmacodynamics of Abacavir in an In Vitro Hollow-Fiber Model System

Drusano, G. L., Bilello, P. A., Symonds, W. T., Stein, D. S., McDowell, J., Bye, A., ...

Abacavir is a potent new carbocyclic nucleoside analogue. We employed our hollow-fiber pharmacodynamic modeling system to examine the antiretroviral effects of different abacavir exposures, as well...

Rational Dose Selection for a Nonnucleoside Reverse Transcriptase Inhibitor through Use of Population Pharmacokinetic Modeling and Monte Carlo Simulation

Drusano, G. L., Moore, K. H. P., Kleim, J. P., Prince, W., Bye, A.

In order to choose a rational dose for GW 420867X, we first set a goal of therapy. We hypothesized that, for optimal antiretroviral activity, the trough free drug concentration should remain above...

Human safety and pharmacokinetics of a single intramuscular dose of a novel spectinomycin analog, trospectomycin (U-63,366F).

Novak, E, Paxton, L M, Bye, A, Patel, R, Zurenko, G E, Francom, S F

In this study, local and systemic tolerance and pharmacokinetics of trospectomycin sulfate in human beings were evaluated for the first time. Trospectomycin sulfate (U-63,366F; trospectomycin) or...

The biosynthesis of 4-hydroxycoumarin and dicoumarol by Aspergillus fumigatus Fresenius

Bye, A., King, H. K.

A strain of Aspergillus fumigatus Fresenius, isolated from spoiled hay, converts melilotic acid (o-hydroxyphenylpropionic acid) and o-coumaric acid into 4-hydroxycoumarin and dicoumarol. The sequence...

Successful treatment of experimental B virus (Herpesvirus simiae) infection with acyclovir.

Boulter, E A, Thornton, B, Bauer, D J, Bye, A

The efficacy of the new nucleoside analogue acyclovir against B virus (Herpesvirus simiae) was investigated in rabbits and Vero cells infected with 2-136 and 0.3-1.0 TCD50 of the virus respectively....

Use of Drug Effect Interaction Modeling with Monte Carlo Simulation To Examine the Impact of Dosing Interval on the Projected Antiviral Activity of the Combination of Abacavir and Amprenavir

Drusano, G. L., D'Argenio, D. Z., Preston, S. L., Barone, C., Symonds, W., LaFon, S., ...

The delineation of optimal regimens for combinations of agents is a difficult problem, in part because, to address it, one needs to (i) have effect relationships between the pathogen in question and...

Nucleoside Analog 1592U89 and Human Immunodeficiency Virus Protease Inhibitor 141W94 Are Synergistic In Vitro

Drusano, G. L., D’Argenio, D. Z., Symonds, W., Bilello, P. A., McDowell, J., Sadler, B., ...

The use of combinations of anti-human immunodeficiency virus (anti-HIV) agents targeted to different molecular targets will most likely result in increased viral suppression and may also delay or...

Pharmacodynamics of Abacavir in an In Vitro Hollow-Fiber Model System

Drusano, G. L., Bilello, P. A., Symonds, W. T., Stein, D. S., McDowell, J., Bye, A., ...

Abacavir is a potent new carbocyclic nucleoside analogue. We employed our hollow-fiber pharmacodynamic modeling system to examine the antiretroviral effects of different abacavir exposures, as well...

Rational Dose Selection for a Nonnucleoside Reverse Transcriptase Inhibitor through Use of Population Pharmacokinetic Modeling and Monte Carlo Simulation

Drusano, G. L., Moore, K. H. P., Kleim, J. P., Prince, W., Bye, A.

In order to choose a rational dose for GW 420867X, we first set a goal of therapy. We hypothesized that, for optimal antiretroviral activity, the trough free drug concentration should remain above...

Human safety and pharmacokinetics of a single intramuscular dose of a novel spectinomycin analog, trospectomycin (U-63,366F).

Novak, E, Paxton, L M, Bye, A, Patel, R, Zurenko, G E, Francom, S F

In this study, local and systemic tolerance and pharmacokinetics of trospectomycin sulfate in human beings were evaluated for the first time. Trospectomycin sulfate (U-63,366F; trospectomycin) or...

The biosynthesis of 4-hydroxycoumarin and dicoumarol by Aspergillus fumigatus Fresenius

Bye, A., King, H. K.

A strain of Aspergillus fumigatus Fresenius, isolated from spoiled hay, converts melilotic acid (o-hydroxyphenylpropionic acid) and o-coumaric acid into 4-hydroxycoumarin and dicoumarol. The sequence...

Successful treatment of experimental B virus (Herpesvirus simiae) infection with acyclovir.

Boulter, E A, Thornton, B, Bauer, D J, Bye, A

The efficacy of the new nucleoside analogue acyclovir against B virus (Herpesvirus simiae) was investigated in rabbits and Vero cells infected with 2-136 and 0.3-1.0 TCD50 of the virus respectively....

The pharmacokinetics of ondansetron after intravenous injection in healthy volunteers phenotyped as poor or extensive metabolisers of debrisoquine.

Ashforth, E I, Palmer, J L, Bye, A, Bedding, A

The pharmacokinetics of the 5-HT3 receptor antagonist ondansetron following an 8 mg i.v. dose were investigated in 12 subjects previously phenotyped with debrisoquine. Six subjects were poor...

Pharmacokinetics of trospectomycin sulphate in healthy subjects after single intravenous and intramuscular doses.

Nichols, D J, Bye, A, Novak, E

The pharmacokinetics of trospectomycin (75-1000 mg free base equivalents) were studied in 128 healthy males (eight per dose group), after a 20 min intravenous (i.v.) infusion and intramuscular (i.m.)...

A simple collection method for saliva in children: potential for home monitoring of carbamazepine therapy.

Chee, K Y, Lee, D, Byron, D, Naidoo, D, Bye, A

We have developed a method of monitoring plasma concentrations of antiepileptic drugs which uses salivary samples, and is suitable for home monitoring in children. To validate the method, paired...

Human gastrointestinal absorption of acyclovir from tablet duodenal infusion and sipped solution.

Lewis, L D, Fowle, A S, Bittiner, S B, Bye, A, Isaacs, P E

On two occasions at least 1 week apart, nine healthy male volunteers were administered in random order either 2 X 200 mg (1.8 mmol) acyclovir tablets or 400 mg of acyclovir in 500 ml of 5% dextrose...

Effect of a single oral dose of aspirin on the platelet aggregation response to arachidonic acid.

Bye, A, Lewis, Y, O'Grady, J

1 The platelet aggregation response to arachidonic acid ex vivo was measured in six volunteers daily before and for 10 days after a single oral dose of 600 mg aspirin. 2 Arachidonic acid induced...

Pharmacokinetics of intravenous fluticasone propionate in healthy subjects

MACKIE, A. E., VENTRESCA, G. P., FULLER, R. W., BYE, A.

1Fluticasone propionate (FP) is a potent glucocorticoid used in the treatment of asthma. Prior to reporting the pharmacokinetics following the inhaled and oral routes, the pharmacokinetics need to be...

Aerobic capacity-dependent differences in cardiac gene expression

Bye, A., Langaas, M., Høydal, M.A., Kemi, O.J., Heinrich, G., Koch, L.G., ...

Aerobic capacity is a strong predictor of cardiovascular mortality. To determine the relationship between inborn aerobic capacity and cardiac gene expression we examined genome-wide gene expression...